Advanced search
1 file | 298.82 KB

Medication-overuse headache in patients with cluster headache

(2006) NEUROLOGY. 67(1). p.109-113
Author
Organization
Abstract
Objective: Medication-overuse headache (MOH) in cluster headache (CH) patients is incompletely described, perhaps because of the relatively low prevalence of CH. Methods: The authors describe a retrospective series of 17 patients (13 men, 4 women) with CH who developed MOH in association with overuse of a wide range of monotherapies or varying combinations of simple analgesics (n = 9), caffeine (n = 1), opioids (n = 10), ergotamine (n = 3), and triptans (n = 14). The series includes both episodic (n = 7) and chronic (n = 10) CH patients. Results: A specific triptan-overuse headache diagnosis was made in 3 patients, an opioid-overuse headache diagnosis was made in 1 patient, and an ergotamine-overuse headache diagnosis was made in 1 patient. In approximately half of the patients (n = 8), the MOH phenotype was a bilateral, dull, and featureless daily headache. In the other 9 patients, the MOH was characterized by at least one associated feature, most commonly nausea (n = 6), exacerbation with head movement (n = 5), or throbbing character of the pain (n = 5). The common denominator in 15 patients was a personal or family history, or both, of migraine. The 2 other patients gave a family history of unspecified headaches. Medication withdrawal was attempted and successful in 13 patients. Conclusions: Medication-overuse headache is a previously underrecognized and treatable problem associated with cluster headache (CH). CH patients should be carefully monitored, especially those with a personal or family history of migraine.
Keywords
SUBCUTANEOUS SUMATRIPTAN, HEMICRANIA CONTINUA, MIGRAINE, PREVALENCE, ERGOTAMINE, MANAGEMENT, SYMPTOMS, FEATURES, DISEASE, ONSET

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 298.82 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Paemeleire, Koen, A Bahra, Stefan Evers, MS Matharu, and Peter J Goadsby. 2006. “Medication-overuse Headache in Patients with Cluster Headache.” Neurology 67 (1): 109–113.
APA
Paemeleire, K., Bahra, A., Evers, S., Matharu, M., & Goadsby, P. J. (2006). Medication-overuse headache in patients with cluster headache. NEUROLOGY, 67(1), 109–113.
Vancouver
1.
Paemeleire K, Bahra A, Evers S, Matharu M, Goadsby PJ. Medication-overuse headache in patients with cluster headache. NEUROLOGY. 2006;67(1):109–13.
MLA
Paemeleire, Koen, A Bahra, Stefan Evers, et al. “Medication-overuse Headache in Patients with Cluster Headache.” NEUROLOGY 67.1 (2006): 109–113. Print.
@article{356114,
  abstract     = {Objective: Medication-overuse headache (MOH) in cluster headache (CH) patients is incompletely described, perhaps because of the relatively low prevalence of CH. Methods: The authors describe a retrospective series of 17 patients (13 men, 4 women) with CH who developed MOH in association with overuse of a wide range of monotherapies or varying combinations of simple analgesics (n = 9), caffeine (n = 1), opioids (n = 10), ergotamine (n = 3), and triptans (n = 14). The series includes both episodic (n = 7) and chronic (n = 10) CH patients. Results: A specific triptan-overuse headache diagnosis was made in 3 patients, an opioid-overuse headache diagnosis was made in 1 patient, and an ergotamine-overuse headache diagnosis was made in 1 patient. In approximately half of the patients (n = 8), the MOH phenotype was a bilateral, dull, and featureless daily headache. In the other 9 patients, the MOH was characterized by at least one associated feature, most commonly nausea (n = 6), exacerbation with head movement (n = 5), or throbbing character of the pain (n = 5). The common denominator in 15 patients was a personal or family history, or both, of migraine. The 2 other patients gave a family history of unspecified headaches. Medication withdrawal was attempted and successful in 13 patients. Conclusions: Medication-overuse headache is a previously underrecognized and treatable problem associated with cluster headache (CH). CH patients should be carefully monitored, especially those with a personal or family history of migraine.},
  author       = {Paemeleire, Koen and Bahra, A and Evers, Stefan and Matharu, MS and Goadsby, Peter J},
  issn         = {0028-3878},
  journal      = {NEUROLOGY},
  language     = {eng},
  number       = {1},
  pages        = {109--113},
  title        = {Medication-overuse headache in patients with cluster headache},
  url          = {http://dx.doi.org/10.1212/01.wnl.0000223332.35936.6e},
  volume       = {67},
  year         = {2006},
}

Altmetric
View in Altmetric
Web of Science
Times cited: